Key Points
- Tesla shares advanced 1% to $332 in pre-market trading Monday, continuing momentum from last week’s nearly 6% rally that broke a three-week decline.
- Individual investor purchases reached $372 million across five trading sessions ending Wednesday, a significant jump from the previous week’s $121 million, J.P. Morgan data shows.
- The electric vehicle manufacturer and SpaceX revealed plans for a $16.8 billion semiconductor manufacturing facility in Texas, dubbed Terafab, to power AI systems, self-driving technology, and humanoid robots.
- While Q2 revenue exceeded forecasts, earnings per share of $0.33 fell short of the $0.50 Wall Street expectation; shares remain down 27% in 2025.
- Wall Street maintains a “Hold” rating overall with a mean price target of $401.74; the stock currently trades at 194 times projected earnings.
Shares of Tesla were up 1% at $332 during Monday’s pre-market session, extending the previous week’s momentum that saw the stock climb nearly 6% and halt a three-week slide.
Monday’s opening price of $328.58 remains notably beneath the 50-day moving average of $378.76 and the 200-day moving average of $393.46.
Year-to-date performance through Friday shows a 27% decline. The stock’s 52-week trading range spans from $297.38 to $498.83, with the company commanding a $1.30 trillion market capitalization.
Individual traders have been returning to the stock in force. Net purchases reached approximately $372 million during the five trading days ending Wednesday, a substantial increase from the previous week’s $121 million, J.P. Morgan tracking data indicates.
Institutional ownership accounts for 66.2% of outstanding shares. World Equity Group expanded its stake by 17.9% during Q2, purchasing 2,011 additional shares to bring its holdings to 13,237 shares valued at roughly $5.57 million.
The Terafab project provided new catalysts for investor interest. Tesla and SpaceX announced an initial commitment of $16.8 billion toward constructing a state-of-the-art chip manufacturing complex in Texas, designed to power artificial intelligence infrastructure, self-driving vehicle systems, and the Optimus humanoid robot program.
Approximately 25% of the facility’s computing resources will be allocated to Tesla initiatives. The Texas plant is anticipated to create roughly 3,000 employment positions.
SpaceX additionally revealed purchases of approximately $295 million in Tesla Megapack energy storage systems during the second quarter, providing a boost to Tesla’s energy division.
Quarterly Results Fall Short on Profits
The company’s Q2 financial results, released July 22, delivered mixed signals. Top-line revenue reached $28.24 billion, surpassing the $26.42 billion analyst projection. This represents a 25.5% increase compared to the year-ago period.
However, earnings per share came in at $0.33, falling $0.17 below the $0.50 Wall Street consensus. Return on equity registered at 3.82%, while net profit margin stood at 3.67%.
Current analyst projections estimate full-year EPS at $0.88. With a PE ratio of 304.24, the valuation implies significant future growth that current profitability hasn’t yet validated.
Tesla currently trades at 194 times anticipated 2026 earnings, approximately 10 turns above its five-year historical average.
Wall Street Views and Executive Transactions
The Street consensus maintains a “Hold” rating, with a mean price objective of $401.74. Canaccord Genuity carries a “Buy” recommendation with a $410 target. Both Jefferies and China Renaissance assign “Hold” ratings, with price targets of $400 and $372 respectively.
Chief Financial Officer Vaibhav Taneja divested 2,606 shares on June 8 at an average price of $402.20, totaling slightly over $1 million. The transaction was executed to satisfy tax liabilities related to vesting equity compensation.
Company insiders collectively control 19.9% of Tesla’s outstanding shares.
On the competitive landscape, Ford’s planned sub-$30,000 Fathom electric pickup truck could create pricing pressure for the Cybertruck. European regulatory votes on Full Self-Driving authorization are slated for October and November.
The stock carries a beta of 1.83, while maintaining a conservative debt-to-equity ratio of 0.09.





